Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Delirium × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Urothelial Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Neoplasms 1 Nausea 1 Liposarcoma 1 Dyspnea 1 Delirium 1 Death 1 Colorectal Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Adenocarcinoma of Lung 1

Interventions

haloperidol decanoate 1 Surveys and Questionnaires 1 Midazolam 1 Melatonin 1 Lorazepam 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡